Richard Ware, 56, was diagnosed with stage 4 prostate cancer in 2022. Last December, he was told that it had spread to his brain. Following his diagnosis, Richard found out that he carries the BRCA2 ...
Researchers from The Institute of Cancer Research, London, will contribute to a £13.7 million research consortium aimed at developing new brain tumour treatments, following an announcement by the NIHR ...
Sue’s husband, Philip, was diagnosed with prostate cancer in 2005 and died on Christmas Day 2009, aged 57. 16 years on, she reflects on the legacy he left behind. It was a complete shock to us both ...
Image: Person walking towards the beach. Credits: Pixabay. Most people are aware of the benefits of exercise – it has been associated with improvements in overall health for some time. It makes sense ...
The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned. According to a new modelling study, published in the journal ...
Doctors could soon be able to better predict an individual patient’s chances of getting cancer and offer them personalised detection and prevention strategies, thanks to a new research project co-led ...
A pioneering clinical trial has demonstrated for the first time that two existing treatments can be combined to potentially improve outcomes for sarcoma and melanoma patients with advanced tumours in ...
A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...
Prostate cancer guidelines should change so that all men from the age of 40 with mutations in either the BRCA1 or BRCA2 gene are offered regular PSA testing to detect early signs of the disease, ...
Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting ...
Image: KRAS-mutated cancer cells. Credit Lisa Pickard / Louise Howell / ICR Researchers are set to to combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models ...
At the ICR, we are interested in how to make cancer treatments kinder and more practical for patients. With prostate cancer being the most common cancer in men in the UK and many other countries, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback